Clinical trial
Effect of 0.12% Chlorhexidine Oral Care for the Prevention of Non-ventilator Hospital-acquired Pneumonia Among Hospitalized Patients
NCT04403971 is registered in ClinicalTrials.gov with National Cheng-Kung University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of 0.12% Chlorhexidine Oral Care for the Prevention of Non-ventilator Hospital-acquired Pneumonia Among Hospitalized Patients
- Lead sponsor
- National Cheng-Kung University Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 25, 2020
- Completion date
- December 31, 2020
- Enrollment
- 103 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hospital-acquired pneumonia